MwanzoME • NASDAQ
add
23andMe Holding Co.
$ 3.11
Baada ya Saa za Kazi:(3.54%)+0.11
$ 3.22
Imefungwa: 22 Nov, 18:26:25 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 3.23
Bei za siku
$ 2.99 - $ 3.21
Bei za mwaka
$ 2.66 - $ 20.20
Thamani ya kampuni katika soko
74.94M USD
Wastani wa hisa zilizouzwa
elfu 404.88
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 44.07M | -11.86% |
Matumizi ya uendeshaji wa biashara | 81.33M | -17.18% |
Mapato halisi | -59.10M | 21.48% |
Kiwango cha faida halisi | -134.11 | 10.91% |
Mapato kwa kila hisa | — | — |
EBITDA | -54.96M | 21.06% |
Asilimia ya kodi ya mapato | 0.07% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 126.60M | -50.62% |
Jumla ya mali | 318.94M | -60.19% |
Jumla ya dhima | 217.01M | 23.31% |
Jumla ya hisa | 101.93M | — |
hisa zilizosalia | 26.12M | — |
Uwiano wa bei na thamani | 0.82 | — |
Faida inayotokana na mali | -42.89% | — |
Faida inayotokana mtaji | -75.30% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -59.10M | 21.48% |
Pesa kutokana na shughuli | -40.93M | 28.34% |
Pesa kutokana na uwekezaji | -2.70M | 2.63% |
Pesa kutokana na ufadhili | elfu 260.00 | -83.68% |
Mabadiliko halisi ya pesa taslimu | -43.37M | 25.18% |
Mtiririko huru wa pesa | -12.82M | 59.90% |
Kuhusu
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
Apr 2006
Makao Makuu
Tovuti
Wafanyakazi
571